Cancer Drug
May Flush Out 'Hidden' HIV: Study
Strategy
could help battle 'reservoir' of germs, but research is in early stages.
By Randy Dotinga. In U.S.
News & World Report
Brittany
Wenger, 17, Wins Google Science Fair Grand Prize For Breast Cancer Diagnosis
App
Have you
ever helped the hard-of-hearing listen to music? Or built a computer program to
diagnose breast cancer? These kids have.
By Dino Grandoni. In Huffington
Post
Pregnancy
post 30 lowers cancer risk
Women who
last give birth at age 40 or older have a 44 per cent decreased risk of
endometrial cancer when compared to women who have their last birth under the
age of 25, a
new study has revealed.
In Times of India
Antioxidants
Might Help Cut Pancreatic Cancer Risk, Study Suggests
But the
research cannot prove cause and effect, and better trials are needed, experts
say.
In U.S.
News & World Report
The National
Cancer Institute estimates in 2012 there will be 226,870 new cases of breast
cancer in women with 39,510 deaths. In response to a need to improve breast
cancer detection and prevention Governor Andrew M. Cuomo signed legislation on
July 23, 2012 that requires mammography services to inform patients if dense
breast tissue is found during an exam.
By Harold Mandel. In The Examiner
Should
cancer be kept secret?
Some hide
life-threatening illnesses from friends and family, but suffer guilt.
By Leanne Italie. In Salon
FDA Approves
Everolimus (Afinitor) for Metastatic Breast Cancer
The US Food and
Drug Administration (FDA) approved the mTOR inhibitor everolimus (Afinitor)
last week for use in postmenopausal women with HER2-negative, hormone-receptor–positive
advanced breast cancer patients. Afinitor was approved in combination with
exemestane(Drug information on exemestane) (Aromasin) in those patients whose
cancer progressed following treatment with letrozole or anastrozole.
By Anna Azvolinsky. In Cancer
Network
New
biomarker for common lung cancer predicts responses to chemotherapy
Patients
with the most common type of lung cancer are notoriously insensitive to
chemotherapy drugs, including cisplatin. New findings related to the cellular
pathways that regulate responses to cisplatin have now been published by Cell
Press on July 26th in the journal Cell Reports. The findings reveal a potential
biomarker that can be used to predict how these patients will respond to
chemotherapy, as well as the patients' overall prognosis, paving the way for
personalized treatment strategies
In EurekAlert (press release)
Limiter le sel pour diminuer le
risque de cancer de l'estomac
Un organisme anglais de prévention du cancer alerte sur
l'impact d'une alimentation trop salée, qui favorise le risque de tumeur à
l'estomac.
Par Romy Raffin. Dans Le Figaro
http://sante.lefigaro.fr/actualite/2012/07/25/18691-limiter-sel-pour-diminuer-risque-cancer-lestomac
Cancer du pancréas : découverte d'un processus qui
bloquerait les métastases
Des scientifiques du centre de recherche en cancérologie de
Marseille (CRCM) ont annoncé avoir identifié un processus cellulaire au sein
des tumeurs pancréatiques qui permettrait de bloquer la formation de
métastases. Une découverte porteuse d'espoir pour ce cancer trop souvent mortel.
Dans MaxiSciences
Un médicament contre le cancer pour débusquer le VIH
Une catégorie de médicaments couramment employés dans le
traitement du cancer permettrait de débusquer le VIH-sida lorsqu'il se cache
sous forme latente dans le sang des malades, affirment des chercheurs
américains.
Dans Radio-Canada.com
Le bronzage en spray pourrait causer des cancers et de
l'infertilité
Bronzer est définitivement une activité risquée. Après les
cabines de bronzage, soupçonnées d'augmenter les risques de cancer, c'est au
tour des autobronzants d'être pointés du doigt par la recherche, rapporte The
Telegraph.
Dans Slate.fr
Aucun commentaire:
Enregistrer un commentaire